Nephros Inc risk profile
22 Normal where most of the sector sits
Measured 21 October 2026 from NEPH's filed statements. Recomputed nightly.
22 (Normal), driven by Market expectation at 75, over 6 weighted categories on the MANUFACTURER profile.
What is measured
| Mechanism | Reading | Band | Direction | Driver |
|---|---|---|---|---|
| Market expectation | 75 | Stretched | Volatile | One-year price volatility — 85.6% |
| Operating pressure | 9 | Contained | Worsening | Costs outgrowing revenue — -7.8 percentage points |
| Cash conversion | 31 | Normal | Easing | Cash conversion — 1.34x |
| Leverage and coverage | 2 | Contained | Stable | Current ratio — 4.06x |
| Competitive position | 20 | Normal | Stable | R&D-intensity gap against peers — -38.5 percentage points |
| Concentration | 25 | Normal | Stable | Customer concentration — 728 HHI |
These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.